Sravan K. Emany - 24 Feb 2026 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Reporting relationship: Director
Issuer ticker: KYTX
Reported as of: 24 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Feb 2026, 16:30:04 UTC
Prior SEC filing: 02 Feb 2026
Next SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Grasso, as Attorney-in-Fact

Key filing fact

Sravan K. Emany filed Form 4 for Kyverna Therapeutics, Inc. (KYTX) on 26 Feb 2026.

Key facts

This page summarizes Sravan K. Emany's Form 4 filing for Kyverna Therapeutics, Inc. (KYTX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Feb 2026, 16:30.

Change

Previous filing in this sequence was filed on 02 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001897662 Primary reporting owner

Emany Sravan Kumar

Relationship: Director
Address: C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE
Signature: /s/ Marc Grasso, as Attorney-in-Fact
Signature date: 26 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KYTX transaction

Common Stock

Award

Transaction value: $0
Shares: +11,006
Change %
Price: $0.000000
Shares after: 11,006
Date: 24 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KYTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +42,945
Change %
Price: $0.000000
Shares after: 42,945
Date: 24 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 42,945
Exercise price: $7.95
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Footnote F2

1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.